Respiratory sinus arrhythmia is reduced after pulmonary vein isolation in patients with paroxysmal atrial fibrillation

Standard

Respiratory sinus arrhythmia is reduced after pulmonary vein isolation in patients with paroxysmal atrial fibrillation. / Jungen, Christiane; Alken, Fares-Alexander; Eickholt, Christian; Scherschel, Katharina; Kuklik, Pawel; Klatt, Niklas; Schwarzl, Jana; Moser, Julia; Jularic, Mario; Akbulak, Ruken Oezge; Schaeffer, Benjamin; Willems, Stephan; Meyer, Christian.

in: ARCH MED SCI, Jahrgang 16, Nr. 5, 2020, S. 1022-1030.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Jungen, C, Alken, F-A, Eickholt, C, Scherschel, K, Kuklik, P, Klatt, N, Schwarzl, J, Moser, J, Jularic, M, Akbulak, RO, Schaeffer, B, Willems, S & Meyer, C 2020, 'Respiratory sinus arrhythmia is reduced after pulmonary vein isolation in patients with paroxysmal atrial fibrillation', ARCH MED SCI, Jg. 16, Nr. 5, S. 1022-1030. https://doi.org/10.5114/aoms.2019.83883

APA

Jungen, C., Alken, F-A., Eickholt, C., Scherschel, K., Kuklik, P., Klatt, N., Schwarzl, J., Moser, J., Jularic, M., Akbulak, R. O., Schaeffer, B., Willems, S., & Meyer, C. (2020). Respiratory sinus arrhythmia is reduced after pulmonary vein isolation in patients with paroxysmal atrial fibrillation. ARCH MED SCI, 16(5), 1022-1030. https://doi.org/10.5114/aoms.2019.83883

Vancouver

Bibtex

@article{cebc9eb48fba4be2889f011a6b2913b0,
title = "Respiratory sinus arrhythmia is reduced after pulmonary vein isolation in patients with paroxysmal atrial fibrillation",
abstract = "Introduction: Respiratory sinus arrhythmia (RSA) describes heart rate (HR) changes in synchrony with respiration. It is relevant for exercise capacity and mechanistically linked with the cardiac autonomic nervous system. After pulmonary vein isolation (PVI), the current therapy of choice for patients with paroxysmal atrial fibrillation (AF), the cardiac vagal tone is often diminished. We hypothesized that RSA is modulated by PVI in patients with paroxysmal AF.Material and methods: Respiratory sinus arrhythmia, measured by using a deep breathing test and heart rate variability parameters, was studied in 10 patients (64 ±3 years) with paroxysmal AF presenting in stable sinus rhythm for their first catheter-based PVI. Additionally, heart rate dynamics before and after PVI were studied during sympathetic/parasympathetic coactivation by using a cold-face test. All tests were performed within 24 h before and 48 h after PVI.Results: After PVI RSA (E/I difference: 7.9 ±1.0 vs. 3.5 ±0.6 bpm, p = 0.006; E/I ratio: 1.14 ±0.02 vs. 1.05 ±0.01, p = 0.003), heart rate variability (SDNN: 31 ±3 vs. 14 ±3 ms, p = 0.006; RMSSD: 17 ±2 vs. 8 ±2 ms, p = 0.002) and the HR response to sympathetic/parasympathetic coactivation (10.2 ±0.7% vs. 5.7 ±1.1%, p = 0.014) were diminished. The PVI-related changes in RSA correlated with the heart rate change during sympathetic/parasympathetic coactivation before vs. after PVI (E/I difference: r = 0.849, p = 0.002; E/I ratio: r = 0.786, p = 0.007). One patient with vagal driven arrhythmia experienced AF recurrence during follow-up (mean: 6.5 ±0.6 months).Conclusions: Respiratory sinus arrhythmia is reduced after PVI in patients with paroxysmal AF. Our findings suggest that this is related to a decrease in cardiac vagal tone. Whether and how this affects the clinical outcome including exercise capacity need to be determined.",
author = "Christiane Jungen and Fares-Alexander Alken and Christian Eickholt and Katharina Scherschel and Pawel Kuklik and Niklas Klatt and Jana Schwarzl and Julia Moser and Mario Jularic and Akbulak, {Ruken Oezge} and Benjamin Schaeffer and Stephan Willems and Christian Meyer",
note = "Copyright: {\textcopyright} 2019 Termedia & Banach.",
year = "2020",
doi = "10.5114/aoms.2019.83883",
language = "English",
volume = "16",
pages = "1022--1030",
journal = "ARCH MED SCI",
issn = "1734-1922",
publisher = "Termedia Publishing House Ltd.",
number = "5",

}

RIS

TY - JOUR

T1 - Respiratory sinus arrhythmia is reduced after pulmonary vein isolation in patients with paroxysmal atrial fibrillation

AU - Jungen, Christiane

AU - Alken, Fares-Alexander

AU - Eickholt, Christian

AU - Scherschel, Katharina

AU - Kuklik, Pawel

AU - Klatt, Niklas

AU - Schwarzl, Jana

AU - Moser, Julia

AU - Jularic, Mario

AU - Akbulak, Ruken Oezge

AU - Schaeffer, Benjamin

AU - Willems, Stephan

AU - Meyer, Christian

N1 - Copyright: © 2019 Termedia & Banach.

PY - 2020

Y1 - 2020

N2 - Introduction: Respiratory sinus arrhythmia (RSA) describes heart rate (HR) changes in synchrony with respiration. It is relevant for exercise capacity and mechanistically linked with the cardiac autonomic nervous system. After pulmonary vein isolation (PVI), the current therapy of choice for patients with paroxysmal atrial fibrillation (AF), the cardiac vagal tone is often diminished. We hypothesized that RSA is modulated by PVI in patients with paroxysmal AF.Material and methods: Respiratory sinus arrhythmia, measured by using a deep breathing test and heart rate variability parameters, was studied in 10 patients (64 ±3 years) with paroxysmal AF presenting in stable sinus rhythm for their first catheter-based PVI. Additionally, heart rate dynamics before and after PVI were studied during sympathetic/parasympathetic coactivation by using a cold-face test. All tests were performed within 24 h before and 48 h after PVI.Results: After PVI RSA (E/I difference: 7.9 ±1.0 vs. 3.5 ±0.6 bpm, p = 0.006; E/I ratio: 1.14 ±0.02 vs. 1.05 ±0.01, p = 0.003), heart rate variability (SDNN: 31 ±3 vs. 14 ±3 ms, p = 0.006; RMSSD: 17 ±2 vs. 8 ±2 ms, p = 0.002) and the HR response to sympathetic/parasympathetic coactivation (10.2 ±0.7% vs. 5.7 ±1.1%, p = 0.014) were diminished. The PVI-related changes in RSA correlated with the heart rate change during sympathetic/parasympathetic coactivation before vs. after PVI (E/I difference: r = 0.849, p = 0.002; E/I ratio: r = 0.786, p = 0.007). One patient with vagal driven arrhythmia experienced AF recurrence during follow-up (mean: 6.5 ±0.6 months).Conclusions: Respiratory sinus arrhythmia is reduced after PVI in patients with paroxysmal AF. Our findings suggest that this is related to a decrease in cardiac vagal tone. Whether and how this affects the clinical outcome including exercise capacity need to be determined.

AB - Introduction: Respiratory sinus arrhythmia (RSA) describes heart rate (HR) changes in synchrony with respiration. It is relevant for exercise capacity and mechanistically linked with the cardiac autonomic nervous system. After pulmonary vein isolation (PVI), the current therapy of choice for patients with paroxysmal atrial fibrillation (AF), the cardiac vagal tone is often diminished. We hypothesized that RSA is modulated by PVI in patients with paroxysmal AF.Material and methods: Respiratory sinus arrhythmia, measured by using a deep breathing test and heart rate variability parameters, was studied in 10 patients (64 ±3 years) with paroxysmal AF presenting in stable sinus rhythm for their first catheter-based PVI. Additionally, heart rate dynamics before and after PVI were studied during sympathetic/parasympathetic coactivation by using a cold-face test. All tests were performed within 24 h before and 48 h after PVI.Results: After PVI RSA (E/I difference: 7.9 ±1.0 vs. 3.5 ±0.6 bpm, p = 0.006; E/I ratio: 1.14 ±0.02 vs. 1.05 ±0.01, p = 0.003), heart rate variability (SDNN: 31 ±3 vs. 14 ±3 ms, p = 0.006; RMSSD: 17 ±2 vs. 8 ±2 ms, p = 0.002) and the HR response to sympathetic/parasympathetic coactivation (10.2 ±0.7% vs. 5.7 ±1.1%, p = 0.014) were diminished. The PVI-related changes in RSA correlated with the heart rate change during sympathetic/parasympathetic coactivation before vs. after PVI (E/I difference: r = 0.849, p = 0.002; E/I ratio: r = 0.786, p = 0.007). One patient with vagal driven arrhythmia experienced AF recurrence during follow-up (mean: 6.5 ±0.6 months).Conclusions: Respiratory sinus arrhythmia is reduced after PVI in patients with paroxysmal AF. Our findings suggest that this is related to a decrease in cardiac vagal tone. Whether and how this affects the clinical outcome including exercise capacity need to be determined.

U2 - 10.5114/aoms.2019.83883

DO - 10.5114/aoms.2019.83883

M3 - SCORING: Journal article

C2 - 32863990

VL - 16

SP - 1022

EP - 1030

JO - ARCH MED SCI

JF - ARCH MED SCI

SN - 1734-1922

IS - 5

ER -